Skip to content

NEOGEN DEVELOPMENTS

Absorbed by Neogen NV KBO/BCE: BE 0808.426.110 subsidiary of Alter Pharma Group NV
NEOGEN DEVELOPMENTS
Follow Report

Mandates through the years

4 names
HANDS-ON FINANCE SOLUTIONS
Director
Jacobsen Management
Director
Alter Pharma NV
Director
GRNR Invest BV
Director
Earliermandate already running before its first mentionend not dated
Mandates as a list
  • HANDS-ON FINANCE SOLUTIONS
    • Director, appointed by deed of 30-03-2020, last mentioned in 2020
  • Jacobsen Management
    • Director, appointed by deed of 30-03-2020, last mentioned in 2020
  • Alter Pharma NV
    • Director, until 12-02-2020
  • GRNR Invest BV
    • Director, until 12-02-2020

Control

Consolidating parent
Alter Pharma Group NV
Equity €127.0m
Loss €16.1m in 2024 (profit €43.5m in 2023)
Source: parent in own accounts 2019
consolidates
This company
NEOGEN DEVELOPMENTS
Equity €292,526
Loss €76,722 in 2019

Capital

Capital
€61,500
Source
2019 annual accounts

Owners through the years

as the annual accounts name them
NEOGEN
99%100%
100%
A.forall Group
consolidates
consolidates
A.forall Development
consolidates1%
1% until 2018
Owners as a list

Source: parent in its own accounts, lists of holdings in the owners' accounts

Capital transactions

Shareholders according to the deeds
Stated in the deed deed of 26-05-2020 ↗

Office holders in the KBO →

Next steps

See who ran this company and where its registered office was, on a date of your choice.Company as of a date See what became of the directors' other companies.Supplier due diligence

We would like to set cookies. That happens only with your consent. What we measure